Investor profile
Hadean Ventures has backed 11 European tech companies across 12 funding rounds between 2018 and 2025, joining rounds totalling €336M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Arthex Biotech | Spain | 2 | €74M |
| Complement Therapeutics | Germany | 1 | €72M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| TargED Biopharmaceutical |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Complement Therapeutics | Series A | €72M | 2023-04 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Arthex Biotech | Series B | €42M | 2023-05 |
| TargED Biopharmaceuticals |
| Netherlands |
| 1 |
| €39M |
| Ribbon Biolabs | Austria | 1 | €18M |
| CardioMech | Norway | 1 | €16M |
| Saga Diagnostics | Sweden | 1 | €3.7M |
| Oncoinvent | Norway | 1 | €3.7M |
| Alex Therapeutics | Sweden | 1 | €3.5M |
| AttgeNo | Sweden | 1 | €3.1M |
| Series A |
| €39M |
| 2022-02 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| Ribbon Biolabs | Series A | €18M | 2022-01 |
| CardioMech | Series A | €16M | 2020-08 |
| Saga Diagnostics | Series A | €3.7M | 2019-04 |
| Oncoinvent | Early VC | €3.7M | 2020-05 |
